Ramdomization and Trial Supply Management
From a regulatory standpoint, adherence to rigorous randomization and RTSM protocols is crucial for gaining approval from regulatory authorities such as the FDA or EMA. These agencies require evidence that the trial design and execution minimize bias and maintain the highest standards of scientific rigor.
